Effect of Adding Vildagliptin to Start of Insulin Treatment in Patients with Type 2 Diabetes.

Trial Profile

Effect of Adding Vildagliptin to Start of Insulin Treatment in Patients with Type 2 Diabetes.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Feb 2013

At a glance

  • Drugs Vildagliptin (Primary) ; Insulin; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 May 2012 Status changed from recruiting to active, no longer recruiting recruiting as reported by Netherlands Trial Register.
    • 15 Jan 2010 Status changed from planning to recruiting as reported by Netherlands Trial Register.
    • 28 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top